Cytokinetics surges 28% on promising heart drug results
Cytokinetics had a strong Tuesday on Wall Street. Shares of the biopharmaceutical company surged 28?ter the firm announced that its drug aficamten had cleared critical targets in a major Phase 3 clinical trial, delivering a piece of welcome news for patients living with a heart condition that currently has no approved treatments specifically designed […] The post Cytokinetics surges 28% on promising heart drug results appeared first on Rolling Out.
Black News 
Cytokinetics had a strong Tuesday on Wall Street. Shares of the biopharmaceutical company surged 28% after the firm announced that its drug aficamten had cleared critical targets in a major Phase 3 clinical trial, delivering a piece of welcome news for patients living with a heart condition that currently has no approved treatments specifically designed […]
The post Cytokinetics surges 28% on promising heart drug results appeared first on Rolling Out.
